Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Dec 19, 2020

30198_dirs_2020-12-18_12b8ccda-84d6-433b-b0e4-cb787e504072.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-12-16

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-16 Common Stock S 600 $352.2 Disposed 13242 Indirect
2020-12-16 Common Stock S 25 $354.0 Disposed 13217 Indirect
2020-12-16 Common Stock S 625 $356.82 Disposed 12592 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 806 Direct

Footnotes

F1: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.